Minerva Neurosciences, Inc. (NERV) Stock Overview
Explore Minerva Neurosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Minerva Neurosciences, Inc. (NERV)
Key Financials
Key Financials
Market Cap
29.4M
P/E Ratio
-0.15
EPS (TTM)
$-1.60
ROE
3.60%
NERV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Minerva Neurosciences, Inc. (NASDAQ: NERV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Minerva Neurosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NERV on the NASDAQ shows an RSI of 43.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.27 for the NASDAQ listing.
Key metrics behind Minerva Neurosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.15 and a market capitalization of 29.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NERV on the NASDAQ.